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Mammalian alria synthesize and secrete a peptide, atrial 
natriuretic factor, with natriuretic and vaswelaxant proper- 
ties (1,2). It is well established lhal sudden changes in atrial 
presum can affect a:rkd natriuretic factor release in nomwd 
atria V-61. In normal humans, sodium loading and passive 
leg raising increase, and upright tilt dccreanes, plasma atria1 
natrluretic factor levels (7-s). Plasma atrial nattiuretk factor 
concentrations are often ekvated in patients with heat 
failure (10-14). Tk effect of chronic atrial hypertension, 
however, on al&l natriuretic factor rqdation is not known. 
This issue is particularly important in patients with conges- 
!ive heart failure, because atrial oatriuretic factor may serve 
as a counter-regulatory hormone, opposing the vasoconstric- 
live and volume-retentive effects of the sympathetic nervous 
system, the renin-angiotensin-aldostrrone system and vase- 
pressin. 
Normally, the plasma levels of the vasocanstrictor hor- 
mones, norepinephrine, angiotensin II and vasopressin, in- 
crease durine maneuvers that decrease cardiac tillina mes- 
swes or blood pressure, such as upri6ht posture or &me 
depletion (15-17). In patients with heaR failure, although 
plasma vasoconstrictor lmnnone concentrations are often 
elevated, they are not affected by suddcncbsrgc, incardiac 
filling pressures (18.19). Dysfunction of cardiopdmonary 
and arterial baroreccptors has bee” reported i” both exper- 
ime”:sl(20-22) and human (23) heart failure and may explain 
the blunted responsiveness of these hormones to sudden 
changes in cardiac loading conditions. 
The parpose of this study was to determine whether 
plasma ztrial “atriuretic factor concentration remains re- 
sponsive to sudden reductions in atria! pressure or is owe- 
sponsive like the vasoconstrictor systems. A dynamic role 
for atrial “auiuretic factor would underscore its potential in 
regulating vascular resistance and sodium excretion during 
sudden changes in posture or volume status in patients with 
congestive heart hilure. To exBmi”e this issue, the plasma 
concentrations of atrial “atriuretic factor, norepinephrine. 
vssopressi” and renin activity were measured in patients 
with chronic congestive hean failure during incremenifil 
lower body “egstive pressure. a maneuver designed to 
suddenly reduce cardiac filling pressures. The results in 
these patients were compared with those obtained in normal 
vobmteers who were subjected to the zame intervention. 
least 24 h before the study. Each study was conducted in B 
2TC temperatuwcontrolled laboratory. 
intensity was ;egulated by a rheastat. 
On arrival in the laboratory, a polyethylene catheter was 
After a 30 min stabilization wriod. baseline hemodv- 
inserted percutaneously into a” antecubital vci” and ad- 
vanced to the superior vena cwa. The catheter was attached 
to a Gould P-23 pressure trawducer and the central ve”o”s 
pressure measurement was displayed on a Gould physiologic 
recorder. Zem reference was chose” to be at the right 
atrium, estimated to be 5 cm vertically beneath the sternal 
angle of Louis. Systolic and diastolic blood pressures were 
determined by sphygmomanometry with “n automated oscil- 
lometric technique (Dinamap, model 845XT, Critikon 
Corp.). Pulse pressure was calculated as the difference 
between systolic and diastolic blwd pressure. Mean blood 
pressure was calculated as the sum of the diastolic blood 
pressure and one third of the pulse pressure. Heart rate was 
determined by a simultaneously obtained electrocardio- 
graphic signal and calculated from the RR interval. To 
reduce cardiac filling pressures, each subject was placed in a 
lower body negative pressure chamber (University of lava. 
Medical Instruments Department). This chamber was sealed 
at the level of the iliac crest. A commercial vacuum cleaner 
was used to o&de a continuous vacuum source whose 
Methods 
Sludy subjects and patients. Twenty normal subjects and 
12 patients with congestive heart failure participated in this 
sttrdy. The protocol WBE approved by the Committee for the 
Protection of Human Subjects from Research Risks at Brig- 
ham and Women’s Hospital and each subject gave wrttten, 
informed consent. The normal group comprised t t men a d 
9 women. aged I9 to 34 yeam (mea” ? SD, 26 r 5). 
Normalcy was established by history, physical examination 
and labwatory analysis, which included a blood cou”t, 
serum glucose concentration and indexes of renal and he- 
patic function. 
Thr patients with chronic congesrive hem foihtre in- 
cluded IO me” and 2 women. Their ages ranged from 46 to 81 
years (mean 63 + 9). The cause of heart failure was coronary 
artery disease in eight patients and primary cardiomyopathy 
in four. Seven of Ihe patients were in New York Heart 
Association functional class III and five were in class IV. 
Left ventricular ejection fraction assessed bv radionuclide 
venrrtculography -aged fmm 7 to 34% &a” 16 2 8%). 
Right heat catheterization was performed in eight of the 
patients with heart failure within 2 days of this-sludy. In 
these patients, cardiac index averaged 2.2 f I.1 literslmin 
Per m’ and pulmonary capillary wedge pressure averaged 33 
+8mmHg. 
Expertme”tal protocol. All studies were conducted in the 
morning with the patient in the postabsorptive stare without 
wemedication. Water was permitted, however, alcohol, 
CatTcine and cigarettes were all prohibited within I2 h of 
study. Vasodilatorand diuretic medications were withheld at 
namic data were collected every Ii min for I h. At the end if 
I h. blood was collected from the central wtws catheter For 
determination of plasma levels of atrial natriuretic factor, 
norepinephrine, rain activity and arginine vasoPressin. 
Thereafter, normal subjects underwent I h periods of incre- 
mental lower body negative pressure at -IO, -20 and -40 
mm Hg. Patients with congestive heart failure underwent a 
similar protocol using negative pressure periods of-10 and 
-40 mm Hg. To maintain patient comfort and cooperation, 
the protocol was shortened by deleting the -20 mm HB 
pmiod. Blood pressure, central venous pressure and heari 
rate were determined every IS min during each expwhnental 
period. Blood was collected for hormonal r,ssays at the 
completion of each period. The experiment was temdnated 
prematurely if symptomatic hypotension occurred. 
Hormonal assays. Blood samples for hormonal assays 
were placed immediately on ice when collected and were 
centrifuged at 2%. P&ma samples were slored at -70°C 
before assay. Blood samples for&al natriuretic factor were 
drawn into chilled vacutainer tubes containing I .S mglml of 
ethylenediami”etetrJaceticacid(EDTA). Plasma atrialnatri- 
uretic factor concentration was measured by radioimmuno- 
assay using a rabbit antibody prepared against synthetic 
human alrial “attiuretic fezto;. The assaywas performed 
according to the procedure described by Peninsula Labora- 
tortes. Synthetic atrial naturetic factor standards, atrial 
natriuretic factor (%126] and I’“-attial natriuretic factor 
199-1261 were obtained fmm Peninsula Laboratories. Assays 
were performed on SepPak extracted plasma. The intraa- 
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diaciohc hlowl pressure was 71 z I mn: Hp. mean blmd 
js+ (\Y 
Pressure was 86 + I nun Hg and pulse prc~sure was 47 C I 
mm Hp. No cignificant change occurred in wtolic, diastolic 
or mean blood pressure during incremental ower body 
negatwe prerwe in the subjects who met the criteria for 
data mclusion. F’ulre pressure decreascc’ significantly during 
the -10 and -40 mm Hg periods to 45 ? 2 and 44 + 2 mm 
HS. wpcc~wcly leach p < 0.05). Baseline central YC~OUF 
pressure was 5.2 2 0.6 mm Hg. Incremental tower body 
CENTRAL VENOUS HEPlRT RATE 
negative pressure decreased central venom pressure to 3.5 
~0.6~p<0.01~.1.4~0.7(p<0.0I~and2.5+ 1.4mmHg 
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PRESSURE 8O (p < 0.05) during the -10. -20 and -40 mm Hg periods. 
respectively. The mean central venous Pressure data during 
say variability in our laboratory is 7.3%. Plasma norepmeph- 
tine concentration war quantified by a modified radioenzy- 
made assay (24). Plasma renin activity and plasma arginine 
vasopressin concentration were determined by radioimmu- 
noassay (25,26). 
swbticpl a&y& The experimental results are pre- 
sented as mean values ? SEM. For each participant. data 
from an experimental period were included only if the 
subject remained in stable condition and completed the 60 
min intewendon. Thus, all data reported were Eollected 
under steady state conditions. The data before and during 
lower body negative pressure for each group were compared 
by analysis of variance far repeated measures with trend 
analysis (27). When the analysis of variatxce indicated a 
statistically significant difference, Dumtett’s test (28) was 
used to zmaly& the difference between two means. Statisti- 
cal significance was accepted at the 95% confidence level (p 
< 0.05). 
the -40 mm Hg period comprised only the mcasurcmcnts in 
the eight remai:Gng subjects. Baseline heart rate was 60 t 2 
beatsknin. Heart rate accelerp!ed at -2!’ and -40 mm Hg to 
6’ : 2 (2 : 0.01) and 79 r 7 beatdmin (p < 0.05). 
i:swctively. 
of the 12 ~&en& with chronic heart failure c&P!atcd the 
entire protocoI. In three Patients. the protwol was termi- 
nated after the patients completed lower body negalive 
pressure at -10 mm Hg because symptomatic hypotension 
occurred duling the -40 mm Hg period. Baseline central 
venous pressure in these three individuals was I, 3 and 4 mm 
Hg. respectively. Baseline systolic blood pressure WBP II3 ? 
3 mm Hg. diastolic blood pressure was 76 * 2 mm Hg. mean 
b!md Pressure was 89 2 2 mm Hg and pulse pressure was 37 
+ 3 mm Hg. Compared with normal subjects. the patients 
with chronic hean failure had a lower baseline pulse pres- 
Hemmlynamic response to incremental lwrr b&y negative 
prrarure in normal subjects (Fi. I). Eight of the 20 normal 
subjects were able to complete the entire protocol and I? 
subjects terminated the protocol after completing the I h 
period of lower body negative pressure at -20 mm Hg. In 
these latter subjects, increasing lower body negative pres- 
sure to -4Q mm Hg resulted in symptomatic hypotension. 
The baeeiine systolic blood pressure was I I8 + I mm Hg, 
sure (p < 0.01). incremental ower body negative pressure 
did not alter an) of these blood pressure variables. In 
contrast to the findmgs in normal subjects, lower WY 
negative pressure did n&t decrease the pulse pressure in the 
heart failure group. The baseline central venous pressure 
was 6.9 ? I .6 mm Hp. According to lhe experimental design, 
incremental lower body negative pressure caused a decrease 
in central venous pres&at both the -10 and -40 mm Hg 
stages to 4.4 + I.6 (p 4 0.01) and 3.4 ? 1.7 mm Hg (p < 
0.01). respectively. Baseline heart rate in these patients was 
84 C 5 beatsimin, a value significantly greater than that 
observed in the normal group (p < 0.01). In contrast to the 
normal subjects, however, no further increase in heart rate 
occurred in the patients with heart failure during lower body 
negative pressure. 
Rormontd response to lower body negative pressure in 
normal subjects (Fig. 3 and 4). The individual basal values 
for plasma concentrations of atrial natriuretic factor, narepi- 
nephrinc, vasopressin and plasma renin activity are illus- 
trated in Figure 3. The hormonal rerpanse to incremental 
lower body negative pressure in the normal group is illus- 
trated in Figure 4. The plarma atrial nalriuretic factor in the 
normal volunteers before intervention averaged 51 + 5 
&ml: the level decreased to 32 2 3 pg/ml during the -20 
mm Hg period (p < 0.01) and to 27 ? 3 pg/ml during the -40 
mm Hg period (p < 0.01). Baseline plasma norepinephrine 
concentration was 194 t II pgiml. Although no significant 
change in plasma norepincphrine level occurred during the 
-10 mm Hg period, the level increased to 262 + 21 (p < 
0.01) and 385 2 76 pglml (p r: 0.05) during the periods of -20 
and -40 mm Hg, respectively. The initial plasma renin 
activity at rest in these normally hydrated subjects was 1.4 f 
0.2 @ml per h. No change in plasma renin activity occurred 
during the -10 mm Hg period. However, incremental lower 
body negative pressure to -20 and -40 mm Hg increased 
plasma rettin activity to 2.4 f 0.3 (p < 0.01) and 3.9 i 0.7 
&ml per h (p < 0.01). respectively. The baseline plasma 
vasorrressin concentration was 1.3 * 0.2 w/ml. No chance in 
pIask vssopressin concentration was &serveB during the 
-10 mm Hg period but the level increased during the -20 
and -40 mm Hg periods to 4.; + I.2 and 6.4 ? 2.4 pg/ml, 
respectively (each p < 0.05). 
Hortnmtal lqlottse to lower body negatiic ptwsw io 
beart failure (Fii. 3 and 5). The individual values fnr plasma 
alrial natriuretic factor, norepinephtine, vasopresnin and 
plasma renin activity. and the group hormonal response to 
Flare 4. Hormonal responses tolower body negadve pressure in 20 
normal subjects. Baseline -10 and -20 mm Hg periods include all 
20 subjects and the -40 mm Hg period ineludes 8subjects. Values 
expressed 8s mean zt SEW 
ATRlALFN$;;JRETIC NGNEPINEPNNINE 
RENIN ACTtVITi AAOlNlNE 
VASOPRESSIN 
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pertension. such as chronic congestive heart failure. When 
admmluered in pharmacologic doses. atrial natriuretic fac- 
1.x has natriuretic. diuretic and vasorelaxant properties 
11,2.2>33). It hw been postulated that this pcptidc may play 
a counter-regulatory role opposing the vawcons;rictive and 
sodium- and water-retcnlive Forces. that is. ptasmacakchol- 
amines. angiotensin 11 and vasopressin. There have been 
,o RENIN dCTI”IIY *.RGIMINE 
many questions raised regarding the physiology cf atrial 
r 9 M~~~~~SSIU natriureric factor in patients with heart failure. One of these c _ 1 is whether atrial natriuretic factor secretion can be regulated 
by decreasing attial pressures or remains siatic like the 
VseoconalriFtor systems. 
Hormonal response to lower body negative pressure in 
b_allM -10 -40 lm*‘lne -10 -40 
nornml subjects. Plasma atrial nalriurelic factor levels ttor- 
LBNP ,rnrn”III LBNP ,fnrnH.$ mally increase in response to increases in atrial volume and 
prcssurcs. Perfusates collected from isolated rat hearts rub- 
Fire 5. Hormonal responses to lower body negative presrure jetted to high central venoK)us pressure have high atrial 
(LBNP) in I2 patients with congestive heart bilure. Baseline and natriurctic faclor levels and demonstrate natriurclic activity 
-10 mm He vericds include all 12 salients and the -40 mm tk l3.4). Plasma atrial natrioretic factor concentration increaser 
inclxmeotal lower body negative pressure in patients with 
congestive heart failure arc displayed in Figures 3 and 5. 
respectively. Compared with the hormonal values. in normal 
subjects, values in patients witl: chronic hean failure ranged 
widely and were frequently elevated. The baseline plasma 
concentmtion of arrial natnurelic factor averaged 438 f 138 
p&d for the heart failure group, a value significantly higher 
rhan that observed in the normal volunteers (p < 0.01). As 
central venous pressure decreased with the application of 
lower body negative pressure. the plasma atria1 oatrioretic 
factor concentraiion tended to decrease at -10 mm Hg (297 
? 89 pg/ml, p = NS) and then decreased significantly at -40 
mm Hg to 317 + gl &ml (p < 0.05). 
Baseline plasma norepinephrine concentration was 614 + 
113 pglml; baseline plasma renin activity was 5.4 2 I .I ng/ml 
per h and baseline plasma concentration of vasopressin was 
4.2 -C 1.0 pe/ml. Each ofthesc values was significantly higher 
@ < 0.01) than the values obtained in the notmal subjects. In 
contrast to findings in the normal subjects. however. iocre- 
mental lower body negative pressure in patients with heart 
failure caused oo further increase in the plasma levels of 
norepinephtine, vasopressin and plasma renin activity. 
Discussion 
The conmi of atrial natriuretic factor release in patho- 
physiologic states is incompletely understood. Although it is 
clear that sudden changes in atrial pressure in the normal 
atriumcan tiect atrial natriuretic factor release, the effect of 
chronic atrial hypertension on atrial natriuretic factor rcgu- 
laiion has not been characterized. This issue is particularly 
relevant in edema states associated with chronic atrial hy- 
in the anesthetized rat and the conscious dog during volume 
expansion and sodium loading (5.6,34). lo nortnal humans. 
salr loading and passive leg raising each increase plasma 
a~riai natriutxtic factor concentration 17-P). When normal 
subjects are tilted. particularly after sodium loading, atrial 
oatriuretic factor levels decrease (7-Q. Our study is one of 
the first to deotonstnte in humans .oat reduction in central 
venous pressure by incremental lower body negative pres- 
sure decreases plasma atria1 natriuretic factorconcentration. 
Thus, alrial distension stimulates secretion of atria1 natri- 
uretic factor whereas reduction in atria1 pressure decreases 
it. 
In normal humans, baroreceptors located in the heart. 
lungs and great vessels rcrpond IO sudden changes in posture 
and volume status by altering the activity of the sympathetic 
nervous system, the reninaniotensin-aldostcrone system 
and the hypophyseal secretion of vasopressin. Orthostasis 
and volume depletion are accompanied by increases in 
plasma catecholamioes, renin activily and vasopresain 
(15-17). as demonstrated in this study. An increase in these 
vasoconstrictive and volume-retentive honones occurred 
only during the higher levels of lower body negative prcs- 
sure. when bw t! central venous pressure and pulse pressure 
were decreased, suggesting that holh cardiopulmonary and 
arterial baroreceptors were unloaded. The simultaneous 
increases in the vasoconstrictor hormone levels and the 
decrease in plasma atrial natriurctic factor level act in 
concert to maintain blood pressure and conserve sodium. 
II has been reported (35.36) that phenylephrine. epineph- 
rifle. angiotensin I1 and vasoprcssin may incrcare plasma 
atrial natriuretic factor levels. The increased secretion of 
atrial natriuretic factor is thought to he a consequence of 
increased atriai prcrsurc induced by these vasoconstrictors 
rather ttan a direct effect of these hormones. In fact, 
adminisfration of the noopressar analog of vasopressin does 
not increase atrial na:riurctic factor levels. and abolishing 
the pressor response of vasopressin prevents an increase in 
atrial satriuretic factor concentration (35). Furthermore. 
neither adreoergic nor mus.xinic blockade inhibits the atrial 
natriuretic factor response to tachycardia or atrial distension 
(37,38). In the normal votuotecrs in this study, the changes in 
atries natriuretic factor levels during lower body negative 
pressure were directionally opposite to the baroreceptor- 
mediated changes in catecholamines, renin and vasopressin. 
Thus, the decrease in the atrial natriuretic factor during 
lower body negative pressure cannot he attributed to these 
neurohumonl mechanisms. 
Atrial natrturetk fetter respeesivenes, in heart failure. 
The plasma concentretion of atriai narrturctic factor is fre- 
quenily increased in ptients with congestive hean failure 
W-14) and appears to correlate with both right and left atrial 
pressure in these patients (12-14). Whether sudden changes 
in atrial pressure alter the secretion of atriai natriuretic 
factor in oaticnrs with chronic atrial hvocnension has not 
been previously examined in a system& meaner. Several 
studies conducted in animals (39) and humans 113.14) SUP 
gest that release of atrtal natriuretic facmr is still responsi& 
to changes in atrial pressure in heart failure. In conscious 
dogs subjected to thoracic inferior vena cava constriction, 
which is a model of low ootpot heart Failure, decreases in 
right and left atrial pressure are accompanied by a decrease 
in plasma atrkd natriuretic factor concentration 04. In 
humans with chronic heart failure subjected to leg raising or 
exercise, which are maneuvers associated with increased 
atrial pressure. atrtal natriuretic factor concentration in- 
creases ll3,!4). 
In lhis smdy. p/mm CvB of orriol narrbrr& factor 
were subsuafially higher in rhe potienlr IW congmive 
hearffailrrre fhan in the normnl volunfccrs. Individual values 
varied widely, and in several patients with heart failure 
exceeded normal vatoes by IO-fold. Plasma atrial natriuretic 
factor levels fell when central venous pressure decreased, 
indicating that chronically stretched atria can still respond to 
decreases in atriat pressure by reducing atrtal natriuretic 
factor secretion. However, it would b premature to state 
that the responsiveocss of atrial oatriuretic factor to reduc- 
lion in atrial pressure was completely pieserved in patients 
with chronic congestive heart failure until the stimulus- 
response relations between atrtal natrturetic factor and atria1 
pressures are carefully compared in normal subjects and 
patients with chronic heart failure. Adaptation of cellular 
mechanisms of atriat natriuretic factor release and depletion 
of its stores, altered atrial compliance or effcrent neural 
impulses may blunt the ability of the atria to respond to 
changes in atrkai pressure. In experimental heart failure. the 
myocardium can express the gene for atrial oatriuretic factor 
(40). Thus. release of atrial natriuretic factor from the failing 
ventricle may also be pertinent to the observations in this 
study. 
Barorxcptor tunctlon in wvgestlve head fattore. In coo- 
trast to the decrease in atriel nntrturetic factor cooeentra. 
lion. plasma levels of noreoineohrine, vasooressin and renin 
activity did not change wi;h l&w body negative preswre. 
Previous studies tt8.19.411 in oatients with chronic heart 
failure demonstated an absent’or significantly blunted re- 
sponse of these hormones to maneuvers that reduce cardiac 
filling pressures. such as tower body negative pressure, 
orthostasis and nitroprusside infusion. Evaluation of card& 
pulmonary and arterial barnreceptors during volume load- 
ing, carotid artery occlusion or phenylephrine infusion have 
shown that the sensitivitv of these receotors is blunted in 
animal models of heart failure (20-22). ‘Barnreceptor dys- 
function may, therefore, explain the lack of change in these 
vasoconsttictor and sodium-retentive hormones in patients 
with chronic heart failure despite the reduction in central 
venous pressure caused by lower body negative pressure. 
Physiakgtc impkations. In normal humans. upright pas- 
tore and volume depletion cause prompt increases in sym- 
pathetic nervous system activity and in secretion of renin 
and vasopressin, effects that preserve Fardiovascular ho- 
meostasis and promote restoration of normal volume a:a:us. 
In patients with chronic congestive heart failure, these 
vasoconstrictor systems are often tonically activated. result- 
ing in excessive vascular resistance and sodium retention. It 
is postulated that baroreceptor dyslunctioa contributes to 
unrestrained vasoconstrtctor activity and inability of these 
systems to modulate changes in blood pressure or body 
water balance. In contrast. atrial natriuretic fanor secretion 
is not mediated by baroretlex mechanisms. As such, it may 
function as an ideal counter-regulatory hormone oppxirtg 
the vasopressor and volume-retentive effects of the vasocon- 
strictor systems. By remaining responsive to changes in 
cardiac filling pressure. atrial natriuretic factor may modu- 
late vascular resistance and fluid balance in patierds with 
heart failure. 
Ltmttattons ef this study. Several factors should be con- 
sidered that may a&t interpretation of the data. First, ooly 
right atrial pressure, and not left atriat pressure, was used to 
assess the responsiveness of atrial natriuretic factor during 
lower body negative pressme. The average right atrial 
pressure in the patients with heart failure did not seem 
substantially higher than that in the noraxd individuals. 
There was, however, considerable variation in the baseline 
right atrial pressure among the patients with heart failure. 
Furthermore, right bcart catheterization performed in the 
majority of the patients with heart failure within 2 days of 
this study confirmed that the pulmonary capillary wedge 
pressure was considerably elevated (33 + g mm Hg; see 
Methods). Therefore, it is likely that an elevated left atrial 
pressure contributed to the increased levels of atrial natri- 
uretic factor in the patients with heart failure. and that left 
atriat pressure decreased during lower body negative prer- 
secretion or ch-ance, Or hmh. Furthermore. the meawre- 
mmt of immunoreactive atria1 natriurctic factor in the 
plasma of our patients does not address the question whether 
larger molecular forms of this factor BE present. Third. the 
protocol used in patients with congestive heart failure was 
shorter than the protocol conducted in the normal wb]ecn. 
In patients with bean fai!ure, the I h period of -20 mm Hg 
was d&ted to msure patient comfort and cooperation. We 
do cat believe that oroloneine the Drotocol would have 
altered the findings in ihe p&n& with’heart failure. Fourth. 9 Yaw,, T. MubasK M. Takrku F. ,,tr,a, “s!ri”relr faor I” human 
our noimal subiects were vouncer than the vatrents wth blaa4 I Cl,” ,““IIl ,98>.,lv11059 
heartfaiture. !t & possible t&t age contributed to the blunted 
responsiveness of the sympathetic nervous system, the 
renirrangiotensin-aldosferone system and vasopressin in the 
patients with heart failure because barorcceptor sensntivitv 
may be decreased in older persons (42.431. However. nt is 
very unlikely that aae would sufficiently extdain the absence 
of change ii these&mmnes in pal& with beart failure 
during lower body negative pressure. 
Condmiom. In both normal subjects and patients with 
chronic congestive heart failure, the plasma concentration of 
atrial natriuretic factor decreases when central venous prcs- 
sure is reduced. Incremental ower body negative pressure is 
accompanied by increases in the plasma lerels of narepi- 
nephrine, vasopressin and rain activity in normal subjects 
but not in patients with heart failure. From these data we 
can&de that the rcspoonsivznxss of atrial natduretic factor 
to reduction in right atriai pressure is preserved in patients 
with hean failure, whereas hanreceptor-mediated increases 
in the activity of the sympathetic nervou.. system, the 
renin-anpiatensin-aldosterone system and vasopressin are 
attenuated or abolished. This imbalance may allow atrial 
natriuretic factor to modulate vascular resistance and IO- 
dium excretion in patients with heart failure during change in 
pasture or volume status. 
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